With nearly two decades of leadership experience in the pharmaceutical industry, including roles as Senior Scientist, Project Leader, Laboratory Head and expert in in vivo pharmacology in Oncology Research at Bayer AG, Antje brings a wealth of scientific and tec.

Antje studied biology at the Humboldt University in Berlin, received her PhD in cell biology from the Max Delbrück Center in Berlin and completed a post-doctoral position at Imperial College London.

Her in-depth knowledge of oncology drug development and deep expertise in pharmacology, particularly in vivo, will further strengthen EPO's leadership in supporting our clients and their programs. Antje will play a key role in advancing our scientific expertise, expanding our portfolio and driving innovative solutions for our clients, with Prof. Wolfgang Walther guiding the transition over the next few months to ensure a smooth handover.

Please feel free to contact Antje directly at Turn on Javascript!

or via LinkedIn.

We look forward to an exciting journey together!

Best regards,

Jens Hoffmann & Wolfgang Walther

CEO & CSO at EPO Berlin-Buch